These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17525716)
21. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E. Levy AP; Blum S Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926 [TBL] [Abstract][Full Text] [Related]
22. Haptoglobin: basic and clinical aspects. Levy AP; Asleh R; Blum S; Levy NS; Miller-Lotan R; Kalet-Litman S; Anbinder Y; Lache O; Nakhoul FM; Asaf R; Farbstein D; Pollak M; Soloveichik YZ; Strauss M; Alshiek J; Livshits A; Schwartz A; Awad H; Jad K; Goldenstein H Antioxid Redox Signal; 2010 Feb; 12(2):293-304. PubMed ID: 19659435 [TBL] [Abstract][Full Text] [Related]
23. Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque. Moreno PR; Purushothaman KR; Purushothaman M; Muntner P; Levy NS; Fuster V; Fallon JT; Lento PA; Winterstern A; Levy AP J Am Coll Cardiol; 2008 Sep; 52(13):1049-51. PubMed ID: 18848136 [TBL] [Abstract][Full Text] [Related]
24. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152 [TBL] [Abstract][Full Text] [Related]
25. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection. Levy Y; Blum S; Levy AP Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773 [TBL] [Abstract][Full Text] [Related]
26. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients. Koda Y; Soejima M; Yamagishi S; Amano S; Okamoto T; Inagaki Y; Yamada K; Kimura H Diabetologia; 2002 Jul; 45(7):1039-40. PubMed ID: 12187922 [No Abstract] [Full Text] [Related]
27. Haptoglobin polymorphism and diabetic nephropathy in Brazilian diabetic patients. Wobeto VP; Garcia PM; Zaccariotto TR; Sonati Mde F Ann Hum Biol; 2009; 36(4):437-41. PubMed ID: 19455468 [TBL] [Abstract][Full Text] [Related]
28. Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene. Levy AP Acta Diabetol; 2003 Dec; 40 Suppl 2():S330-3. PubMed ID: 14704863 [TBL] [Abstract][Full Text] [Related]
29. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease. Goldenstein H; Levy NS; Levy AP Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143 [TBL] [Abstract][Full Text] [Related]
30. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility. Conway BR; Savage DA; Brady HR; Maxwell AP Nephron Exp Nephrol; 2007; 105(3):e75-9. PubMed ID: 17220636 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability. Levy AP; Purushothaman KR; Levy NS; Purushothaman M; Strauss M; Asleh R; Marsh S; Cohen O; Moestrup SK; Moller HJ; Zias EA; Benhayon D; Fuster V; Moreno PR Circ Res; 2007 Jul; 101(1):106-10. PubMed ID: 17525367 [TBL] [Abstract][Full Text] [Related]
32. Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques. Lioupis C; Barbatis C; Drougou A; Koliaraki V; Mamalaki A; Klonaris C; Georgopoulos S; Andrikopoulos V; Bastounis E Atherosclerosis; 2011 May; 216(1):131-8. PubMed ID: 21316675 [TBL] [Abstract][Full Text] [Related]
33. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population. Amor AJ; Canivell S; Oriola J; Ricart MJ; de Hollanda AM; Bosch-Comas A; Esmatjes E Nefrologia; 2014; 34(2):212-5. PubMed ID: 24658196 [TBL] [Abstract][Full Text] [Related]
34. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients]. Moleda P; Majkowska L; Safranow K; Adler G; Goracy I Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464 [TBL] [Abstract][Full Text] [Related]
35. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes? Vardi M; Levy AP Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005 [TBL] [Abstract][Full Text] [Related]
36. The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice. Dahan I; Thawho N; Farber E; Nakhoul N; Asleh R; Levy AP; Li YC; Ben-Izhak O; Nakhoul F J Diabetes Res; 2018; 2018():7163652. PubMed ID: 30250850 [TBL] [Abstract][Full Text] [Related]
37. Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans. Park KU; Song J; Kim JQ J Clin Pathol; 2004 Oct; 57(10):1094-5. PubMed ID: 15452167 [TBL] [Abstract][Full Text] [Related]
38. Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients. Wang S; Wang J; Zhang R; Wang T; Yan D; He Z; Jiang F; Hu C; Jia W Cardiovasc Diabetol; 2018 Jan; 17(1):14. PubMed ID: 29338727 [TBL] [Abstract][Full Text] [Related]
39. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Asleh R; Guetta J; Kalet-Litman S; Miller-Lotan R; Levy AP Circ Res; 2005 Mar; 96(4):435-41. PubMed ID: 15662028 [TBL] [Abstract][Full Text] [Related]
40. Comment to: F. M. Nackhoul et al. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44: 602-604. Schaer DJ Diabetologia; 2001 Nov; 44(11):2104-5. PubMed ID: 11719844 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]